Cambridge, Mass. . . . ChromaDex Inc. and Bayer AG have completed a technology transfer agreement employing yet2.com, a global marketplace for the exchange of intellectual assets on the Internet. The terms of the agreement specify that Bayer AG will license its bioluminescence, thinlayer chromatography toxicity (BIO-TLC) technology to ChromaDex, a supplier of phytochemical reference standards and toxicity screening tools. ChromaDex and Bayer will jointly trademark products that ChromaDex develops using the Bayer BIO-TLC technology.